ID   KCND2_RAT               Reviewed;         630 AA.
AC   Q63881; Q00090; Q99249;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 185.
DE   RecName: Full=A-type voltage-gated potassium channel KCND2 {ECO:0000305};
DE   AltName: Full=Potassium voltage-gated channel subfamily D member 2;
DE   AltName: Full=RK5 {ECO:0000303|PubMed:1705709, ECO:0000303|PubMed:1722463};
DE   AltName: Full=Shal1 {ECO:0000303|PubMed:1840649};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4.2 {ECO:0000303|PubMed:9093524};
GN   Name=Kcnd2 {ECO:0000312|RGD:68393};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY
RP   REGULATION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Hippocampus;
RX   PubMed=1840649; DOI=10.1016/0896-6273(91)90299-f;
RA   Baldwin T.J., Tsaur M.-L., Lopez G.A., Jan Y.N., Jan L.Y.;
RT   "Characterization of a mammalian cDNA for an inactivating voltage-sensitive
RT   K+ channel.";
RL   Neuron 7:471-483(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Heart;
RX   PubMed=1705709; DOI=10.1073/pnas.88.5.1798;
RA   Roberds S.L., Tamkun M.M.;
RT   "Cloning and tissue-specific expression of five voltage-gated potassium
RT   channel cDNAs expressed in rat heart.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:1798-1802(1991).
RN   [3]
RP   FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, SUBCELLULAR LOCATION,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=1722463; DOI=10.1016/0014-5793(91)81420-d;
RA   Blair T.A., Roberds S.L., Tamkun M.M., Hartshorne R.P.;
RT   "Functional characterization of RK5, a voltage-gated K+ channel cloned from
RT   the rat cardiovascular system.";
RL   FEBS Lett. 295:211-213(1991).
RN   [4]
RP   FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, SUBCELLULAR LOCATION,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9093524; DOI=10.1016/s0008-6363(96)00221-0;
RA   Yeola S.W., Snyders D.J.;
RT   "Electrophysiological and pharmacological correspondence between Kv4.2
RT   current and rat cardiac transient outward current.";
RL   Cardiovasc. Res. 33:540-547(1997).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, ACTIVITY REGULATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=9058605;
RA   Sanguinetti M.C., Johnson J.H., Hammerland L.G., Kelbaugh P.R.,
RA   Volkmann R.A., Saccomano N.A., Mueller A.L.;
RT   "Heteropodatoxins: peptides isolated from spider venom that block Kv4.2
RT   potassium channels.";
RL   Mol. Pharmacol. 51:491-498(1997).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9070739; DOI=10.1016/s0306-4522(96)00561-1;
RA   Alonso G., Widmer H.;
RT   "Clustering of KV4.2 potassium channels in postsynaptic membrane of rat
RT   supraoptic neurons: an ultrastructural study.";
RL   Neuroscience 77:617-621(1997).
RN   [7]
RP   PHOSPHORYLATION AT THR-38 AND SER-552 BY PKACA.
RX   PubMed=10681507; DOI=10.1074/jbc.275.8.5337;
RA   Anderson A.E., Adams J.P., Qian Y., Cook R.G., Pfaffinger P.J.,
RA   Sweatt J.D.;
RT   "Kv4.2 phosphorylation by cyclic AMP-dependent protein kinase.";
RL   J. Biol. Chem. 275:5337-5346(2000).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10860776; DOI=10.1006/jmcc.2000.1172;
RA   Takeuchi S., Takagishi Y., Yasui K., Murata Y., Toyama J., Kodama I.;
RT   "Voltage-gated K(+)Channel, Kv4.2, localizes predominantly to the
RT   transverse-axial tubular system of the rat myocyte.";
RL   J. Mol. Cell. Cardiol. 32:1361-1369(2000).
RN   [9]
RP   PHOSPHORYLATION AT THR-602; THR-607 AND SER-616.
RX   PubMed=11080179; DOI=10.1046/j.1471-4159.2000.0752277.x;
RA   Adams J.P., Anderson A.E., Varga A.W., Dineley K.T., Cook R.G.,
RA   Pfaffinger P.J., Sweatt J.D.;
RT   "The A-type potassium channel Kv4.2 is a substrate for the mitogen-
RT   activated protein kinase ERK.";
RL   J. Neurochem. 75:2277-2287(2000).
RN   [10]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH FILAMIN.
RX   PubMed=11102480; DOI=10.1523/jneurosci.20-23-08736.2000;
RA   Petrecca K., Miller D.M., Shrier A.;
RT   "Localization and enhanced current density of the Kv4.2 potassium channel
RT   by interaction with the actin-binding protein filamin.";
RL   J. Neurosci. 20:8736-8744(2000).
RN   [11]
RP   INTERACTION WITH KCNIP1; KCNIP2 AND KCNIP3, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10676964; DOI=10.1038/35000592;
RA   An W.F., Bowlby M.R., Betty M., Cao J., Ling H.-P., Mendoza G.,
RA   Hinson J.W., Mattsson K.I., Strassle B.W., Trimmer J.S., Rhodes K.J.;
RT   "Modulation of A-type potassium channels by a family of calcium sensors.";
RL   Nature 403:553-556(2000).
RN   [12]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, INTERACTION
RP   WITH KCNIP3, SUBCELLULAR LOCATION, MUTAGENESIS OF SER-552, AND
RP   PHOSPHORYLATION AT SER-552.
RX   PubMed=12451113; DOI=10.1523/jneurosci.22-23-10123.2002;
RA   Schrader L.A., Anderson A.E., Mayne A., Pfaffinger P.J., Sweatt J.D.;
RT   "PKA modulation of Kv4.2-encoded A-type potassium channels requires
RT   formation of a supramolecular complex.";
RL   J. Neurosci. 22:10123-10133(2002).
RN   [13]
RP   INTERACTION WITH KCNIP4, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11847232; DOI=10.1074/jbc.m200897200;
RA   Morohashi Y., Hatano N., Ohya S., Takikawa R., Watabiki T., Takasugi N.,
RA   Imaizumi Y., Tomita T., Iwatsubo T.;
RT   "Molecular cloning and characterization of CALP/KChIP4, a novel EF-hand
RT   protein interacting with presenilin 2 and voltage-gated potassium channel
RT   subunit Kv4.";
RL   J. Biol. Chem. 277:14965-14975(2002).
RN   [14]
RP   MUTAGENESIS OF 627-VAL--LEU-630, INTERACTION WITH DLG4, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11923279; DOI=10.1074/jbc.m109412200;
RA   Wong W., Newell E.W., Jugloff D.G.M., Jones O.T., Schlichter L.C.;
RT   "Cell surface targeting and clustering interactions between heterologously
RT   expressed PSD-95 and the Shal voltage-gated potassium channel, Kv4.2.";
RL   J. Biol. Chem. 277:20423-20430(2002).
RN   [15]
RP   INTERACTION WITH KCNIP4.
RX   PubMed=11805342; DOI=10.1073/pnas.022509299;
RA   Holmqvist M.H., Cao J., Hernandez-Pineda R., Jacobson M.D., Carroll K.I.,
RA   Sung M.A., Betty M., Ge P., Gilbride K.J., Brown M.E., Jurman M.E.,
RA   Lawson D., Silos-Santiago I., Xie Y., Covarrubias M., Rhodes K.J.,
RA   Distefano P.S., An W.F.;
RT   "Elimination of fast inactivation in Kv4 A-type potassium channels by an
RT   auxiliary subunit domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:1035-1040(2002).
RN   [16]
RP   PHOSPHORYLATION AT SER-552, AND SUBCELLULAR LOCATION.
RX   PubMed=12829703; DOI=10.1074/jbc.m306142200;
RA   Shibata R., Misonou H., Campomanes C.R., Anderson A.E., Schrader L.A.,
RA   Doliveira L.C., Carroll K.I., Sweatt J.D., Rhodes K.J., Trimmer J.S.;
RT   "A fundamental role for KChIPs in determining the molecular properties and
RT   trafficking of Kv4.2 potassium channels.";
RL   J. Biol. Chem. 278:36445-36454(2003).
RN   [17]
RP   SUBCELLULAR LOCATION, DENDRITIC TARGETING REGION, MUTAGENESIS OF
RP   481-LEU--LEU-482, AND FUNCTION.
RX   PubMed=12592409; DOI=10.1038/nn1020;
RA   Rivera J.F., Ahmad S., Quick M.W., Liman E.R., Arnold D.B.;
RT   "An evolutionarily conserved dileucine motif in Shal K+ channels mediates
RT   dendritic targeting.";
RL   Nat. Neurosci. 6:243-250(2003).
RN   [18]
RP   INTERACTION WITH DPP6.
RX   PubMed=12575952; DOI=10.1016/s0896-6273(02)01185-6;
RA   Nadal M.S., Ozaita A., Amarillo Y., Vega-Saenz de Miera E., Ma Y., Mo W.,
RA   Goldberg E.M., Misumi Y., Ikehara Y., Neubert T.A., Rudy B.;
RT   "The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical
RT   component of neuronal A-type K+ channels.";
RL   Neuron 37:449-461(2003).
RN   [19]
RP   SUBUNIT, ZINC-BINDING, SUBCELLULAR LOCATION, FUNCTION, TRANSPORTER
RP   ACTIVITY, AND MUTAGENESIS OF HIS-105; CYS-111; CYS-132 AND CYS-133.
RX   PubMed=12754210; DOI=10.1074/jbc.m304268200;
RA   Strang C., Kunjilwar K., DeRubeis D., Peterson D., Pfaffinger P.J.;
RT   "The role of Zn2+ in Shal voltage-gated potassium channel formation.";
RL   J. Biol. Chem. 278:31361-31371(2003).
RN   [20]
RP   MUTAGENESIS OF 627-VAL--LEU-630, INTERACTION WITH DLG4, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=14559911; DOI=10.1074/jbc.m304675200;
RA   Wong W., Schlichter L.C.;
RT   "Differential recruitment of Kv1.4 and Kv4.2 to lipid rafts by PSD-95.";
RL   J. Biol. Chem. 279:444-452(2004).
RN   [21]
RP   FUNCTION, TRANSPORTER ACTIVITY, INTERACTION WITH KCNIP3, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15485870; DOI=10.1074/jbc.m409721200;
RA   Kunjilwar K., Strang C., DeRubeis D., Pfaffinger P.J.;
RT   "KChIP3 rescues the functional expression of Shal channel tetramerization
RT   mutants.";
RL   J. Biol. Chem. 279:54542-54551(2004).
RN   [22]
RP   INTERACTION WITH KCNIP1 AND KCNIP3.
RX   PubMed=15356203; DOI=10.1523/jneurosci.0776-04.2004;
RA   Rhodes K.J., Carroll K.I., Sung M.A., Doliveira L.C., Monaghan M.M.,
RA   Burke S.L., Strassle B.W., Buchwalder L., Menegola M., Cao J., An W.F.,
RA   Trimmer J.S.;
RT   "KChIPs and Kv4 alpha subunits as integral components of A-type potassium
RT   channels in mammalian brain.";
RL   J. Neurosci. 24:7903-7915(2004).
RN   [23]
RP   INTERACTION WITH KCNIP1, AND MUTAGENESIS OF 7-ALA--PHE-11; GLU-71; ASP-73;
RP   PHE-74 AND GLU-79.
RX   PubMed=14980207; DOI=10.1016/s0896-6273(04)00049-2;
RA   Scannevin R.H., Wang K., Jow F., Megules J., Kopsco D.C., Edris W.,
RA   Carroll K.C., Lu Q., Xu W., Xu Z., Katz A.H., Olland S., Lin L., Taylor M.,
RA   Stahl M., Malakian K., Somers W., Mosyak L., Bowlby M.R., Chanda P.,
RA   Rhodes K.J.;
RT   "Two N-terminal domains of Kv4 K(+) channels regulate binding to and
RT   modulation by KChIP1.";
RL   Neuron 41:587-598(2004).
RN   [24]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH
RP   KCNIP2, AND DOMAIN.
RX   PubMed=15452711; DOI=10.1007/s00424-004-1328-8;
RA   Pourrier M., Herrera D., Caballero R., Schram G., Wang Z., Nattel S.;
RT   "The Kv4.2 N-terminal restores fast inactivation and confers KChlP2
RT   modulatory effects on N-terminal-deleted Kv1.4 channels.";
RL   Pflugers Arch. 449:235-247(2004).
RN   [25]
RP   REVIEW.
RX   PubMed=15858231; DOI=10.1385/cbb:42:2:167;
RA   Cox R.H.;
RT   "Molecular determinants of voltage-gated potassium currents in vascular
RT   smooth muscle.";
RL   Cell Biochem. Biophys. 42:167-195(2005).
RN   [26]
RP   FUNCTION, TRANSPORTER ACTIVITY, INTERACTION WITH DPP6 AND DPP10, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15671030; DOI=10.1074/jbc.m410613200;
RA   Zagha E., Ozaita A., Chang S.Y., Nadal M.S., Lin U., Saganich M.J.,
RA   McCormack T., Akinsanya K.O., Qi S.Y., Rudy B.;
RT   "DPP10 modulates Kv4-mediated A-type potassium channels.";
RL   J. Biol. Chem. 280:18853-18861(2005).
RN   [27]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15736227; DOI=10.1002/cne.20443;
RA   Strassle B.W., Menegola M., Rhodes K.J., Trimmer J.S.;
RT   "Light and electron microscopic analysis of KChIP and Kv4 localization in
RT   rat cerebellar granule cells.";
RL   J. Comp. Neurol. 484:144-155(2005).
RN   [28]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16207878; DOI=10.1523/jneurosci.2858-05.2005;
RA   Yuan W., Burkhalter A., Nerbonne J.M.;
RT   "Functional role of the fast transient outward K+ current IA in pyramidal
RT   neurons in (rat) primary visual cortex.";
RL   J. Neurosci. 25:9185-9194(2005).
RN   [29]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, SUBUNIT, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16123112; DOI=10.1113/jphysiol.2005.087858;
RA   Jerng H.H., Kunjilwar K., Pfaffinger P.J.;
RT   "Multiprotein assembly of Kv4.2, KChIP3 and DPP10 produces ternary channel
RT   complexes with ISA-like properties.";
RL   J. Physiol. (Lond.) 568:767-788(2005).
RN   [30]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH
RP   KCNIP2, AND DOMAIN.
RX   PubMed=16820361; DOI=10.1074/jbc.m604843200;
RA   Han W., Nattel S., Noguchi T., Shrier A.;
RT   "C-terminal domain of Kv4.2 and associated KChIP2 interactions regulate
RT   functional expression and gating of Kv4.2.";
RL   J. Biol. Chem. 281:27134-27144(2006).
RN   [31]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=17026528; DOI=10.1111/j.1471-4159.2006.04185.x;
RA   Lauver A., Yuan L.L., Jeromin A., Nadin B.M., Rodriguez J.J., Davies H.A.,
RA   Stewart M.G., Wu G.Y., Pfaffinger P.J.;
RT   "Manipulating Kv4.2 identifies a specific component of hippocampal
RT   pyramidal neuron A-current that depends upon Kv4.2 expression.";
RL   J. Neurochem. 99:1207-1223(2006).
RN   [32]
RP   REVIEW.
RX   PubMed=17917103; DOI=10.1007/s12035-007-8001-0;
RA   Baranauskas G.;
RT   "Ionic channel function in action potential generation: current
RT   perspective.";
RL   Mol. Neurobiol. 35:129-150(2007).
RN   [33]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=17582333; DOI=10.1016/j.neuron.2007.05.026;
RA   Kim J., Jung S.C., Clemens A.M., Petralia R.S., Hoffman D.A.;
RT   "Regulation of dendritic excitability by activity-dependent trafficking of
RT   the A-type K+ channel subunit Kv4.2 in hippocampal neurons.";
RL   Neuron 54:933-947(2007).
RN   [34]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18371079; DOI=10.1111/j.1460-9568.2008.06141.x;
RA   Kollo M., Holderith N., Antal M., Nusser Z.;
RT   "Unique clustering of A-type potassium channels on different cell types of
RT   the main olfactory bulb.";
RL   Eur. J. Neurosci. 27:1686-1699(2008).
RN   [35]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-552, AND MUTAGENESIS OF
RP   SER-552.
RX   PubMed=18650329; DOI=10.1523/jneurosci.1951-08.2008;
RA   Hammond R.S., Lin L., Sidorov M.S., Wikenheiser A.M., Hoffman D.A.;
RT   "Protein kinase A mediates activity-dependent Kv4.2 channel trafficking.";
RL   J. Neurosci. 28:7513-7519(2008).
RN   [36]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, SUBUNIT, AND
RP   MISCELLANEOUS.
RX   PubMed=18276729; DOI=10.1113/jphysiol.2007.150540;
RA   Amarillo Y., De Santiago-Castillo J.A., Dougherty K., Maffie J., Kwon E.,
RA   Covarrubias M., Rudy B.;
RT   "Ternary Kv4.2 channels recapitulate voltage-dependent inactivation
RT   kinetics of A-type K+ channels in cerebellar granule neurons.";
RL   J. Physiol. (Lond.) 586:2093-2106(2008).
RN   [37]
RP   REVIEW.
RX   PubMed=18357523; DOI=10.1007/s11064-008-9650-8;
RA   Covarrubias M., Bhattacharji A., De Santiago-Castillo J.A., Dougherty K.,
RA   Kaulin Y.A., Na-Phuket T.R., Wang G.;
RT   "The neuronal Kv4 channel complex.";
RL   Neurochem. Res. 33:1558-1567(2008).
RN   [38]
RP   SUBCELLULAR LOCATION, INTERACTION WITH DPP6 AND KCNIP2, PHOSPHORYLATION AT
RP   SER-548; SER-552; SER-572 AND SER-575, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND MUTAGENESIS OF SER-552.
RX   PubMed=19441798; DOI=10.1021/bi802316m;
RA   Seikel E., Trimmer J.S.;
RT   "Convergent modulation of Kv4.2 channel alpha subunits by structurally
RT   distinct DPPX and KChIP auxiliary subunits.";
RL   Biochemistry 48:5721-5730(2009).
RN   [39]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBUNIT, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19901547; DOI=10.4161/chan.3.6.10216;
RA   Jerng H.H., Dougherty K., Covarrubias M., Pfaffinger P.J.;
RT   "A novel N-terminal motif of dipeptidyl peptidase-like proteins produces
RT   rapid inactivation of KV4.2 channels by a pore-blocking mechanism.";
RL   Channels 3:448-461(2009).
RN   [40]
RP   INTERACTION WITH DLG1.
RX   PubMed=19213956; DOI=10.1161/circresaha.108.191007;
RA   El-Haou S., Balse E., Neyroud N., Dilanian G., Gavillet B., Abriel H.,
RA   Coulombe A., Jeromin A., Hatem S.N.;
RT   "Kv4 potassium channels form a tripartite complex with the anchoring
RT   protein SAP97 and CaMKII in cardiac myocytes.";
RL   Circ. Res. 104:758-769(2009).
RN   [41]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19279261; DOI=10.1523/jneurosci.4767-08.2009;
RA   Kaulin Y.A., De Santiago-Castillo J.A., Rocha C.A., Nadal M.S., Rudy B.,
RA   Covarrubias M.;
RT   "The dipeptidyl-peptidase-like protein DPP6 determines the unitary
RT   conductance of neuronal Kv4.2 channels.";
RL   J. Neurosci. 29:3242-3251(2009).
RN   [42]
RP   SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH PKA; CAV3; AKAP6 AND KCND3,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=20224290; DOI=10.4161/chan.4.3.11479;
RA   Alday A., Urrutia J., Gallego M., Casis O.;
RT   "Alpha1-adrenoceptors regulate only the caveolae-located subpopulation of
RT   cardiac K(V)4 channels.";
RL   Channels 4:168-178(2010).
RN   [43]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=20045463; DOI=10.1016/j.mcn.2009.12.005;
RA   Lin L., Sun W., Wikenheiser A.M., Kung F., Hoffman D.A.;
RT   "KChIP4a regulates Kv4.2 channel trafficking through PKA phosphorylation.";
RL   Mol. Cell. Neurosci. 43:315-325(2010).
RN   [44]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=22098631; DOI=10.1111/j.1460-9568.2011.07907.x;
RA   Kerti K., Lorincz A., Nusser Z.;
RT   "Unique somato-dendritic distribution pattern of Kv4.2 channels on
RT   hippocampal CA1 pyramidal cells.";
RL   Eur. J. Neurosci. 35:66-75(2012).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548; SER-552; SER-572 AND
RP   SER-575, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [46]
RP   INDUCTION BY HYPOXIA, FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=25352783; DOI=10.3389/fncel.2014.00329;
RA   Liu Y.Q., Huang W.X., Sanchez R.M., Min J.W., Hu J.J., He X.H., Peng B.W.;
RT   "Regulation of Kv4.2 A-type potassium channels in HEK-293 cells by
RT   hypoxia.";
RL   Front. Cell. Neurosci. 8:329-329(2014).
RN   [47]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=24037673; DOI=10.1002/cne.23435;
RA   Rainnie D.G., Hazra R., Dabrowska J., Guo J.D., Li C.C., Dewitt S.,
RA   Muly E.C.;
RT   "Distribution and functional expression of Kv4 family alpha subunits and
RT   associated KChIP beta subunits in the bed nucleus of the stria
RT   terminalis.";
RL   J. Comp. Neurol. 522:609-625(2014).
RN   [48]
RP   INTERACTION WITH KCNIP4.
RX   PubMed=24811166; DOI=10.1074/jbc.m114.563452;
RA   Kitazawa M., Kubo Y., Nakajo K.;
RT   "The stoichiometry and biophysical properties of the Kv4 potassium channel
RT   complex with K+ channel-interacting protein (KChIP) subunits are variable,
RT   depending on the relative expression level.";
RL   J. Biol. Chem. 289:17597-17609(2014).
RN   [49]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=24793047; DOI=10.1007/s00424-014-1521-3;
RA   Rudakova E., Wagner M., Frank M., Volk T.;
RT   "Localization of Kv4.2 and KChIP2 in lipid rafts and modulation of outward
RT   K(+) currents by membrane cholesterol content in rat left ventricular
RT   myocytes.";
RL   Pflugers Arch. 467:299-309(2015).
RN   [50]
RP   FUNCTION, PHOSPHORYLATION AT SER-438, AND SUBCELLULAR LOCATION.
RX   PubMed=24404150; DOI=10.1371/journal.pone.0084086;
RA   Labno A., Warrier A., Wang S., Zhang X.;
RT   "Local plasticity of dendritic excitability can be autonomous of synaptic
RT   plasticity and regulated by activity-based phosphorylation of Kv4.2.";
RL   PLoS ONE 9:E84086-E84086(2014).
RN   [51]
RP   SPECIFIC INHIBITION BY SCORPION TOXIN.
RX   PubMed=27346450; DOI=10.1016/j.toxicon.2016.06.014;
RA   Pucca M.B., Cerni F.A., Cordeiro F.A., Peigneur S., Cunha T.M., Tytgat J.,
RA   Arantes E.C.;
RT   "Ts8 scorpion toxin inhibits the Kv4.2 channel and produces nociception in
RT   vivo.";
RL   Toxicon 119:244-252(2016).
RN   [52] {ECO:0007744|PDB:1NN7}
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 42-146 IN COMPLEX WITH ZINC IONS,
RP   AND MUTAGENESIS OF LEU-66 AND ARG-93.
RX   PubMed=12835418; DOI=10.1073/pnas.1432840100;
RA   Nanao M.H., Zhou W., Pfaffinger P.J., Choe S.;
RT   "Determining the basis of channel-tetramerization specificity by X-ray
RT   crystallography and a sequence-comparison algorithm: family values
RT   (FamVal).";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:8670-8675(2003).
RN   [53] {ECO:0007744|PDB:1S6C}
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-30, FUNCTION, TRANSPORTER
RP   ACTIVITY, INTERACTION WITH KCNIP1; KCNIP2 AND KCNIP3, SUBUNIT, SUBCELLULAR
RP   LOCATION, MUTAGENESIS OF TRP-8 AND PHE-11, AND DOMAIN.
RX   PubMed=14980206; DOI=10.1016/s0896-6273(04)00045-5;
RA   Zhou W., Qian Y., Kunjilwar K., Pfaffinger P.J., Choe S.;
RT   "Structural insights into the functional interaction of KChIP1 with Shal-
RT   type K(+) channels.";
RL   Neuron 41:573-586(2004).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates transmembrane
CC       potassium transport in excitable membranes, primarily in the brain, but
CC       also in rodent heart (PubMed:10676964, PubMed:12592409,
CC       PubMed:12754210, PubMed:14980206, PubMed:16123112, PubMed:16207878,
CC       PubMed:1722463, PubMed:1840649, PubMed:19279261, PubMed:25352783,
CC       PubMed:9058605, PubMed:9093524). Mediates the major part of the
CC       dendritic A-type current I(SA) in brain neurons (PubMed:16207878,
CC       PubMed:17026528). This current is activated at membrane potentials that
CC       are below the threshold for action potentials. It regulates neuronal
CC       excitability, prolongs the latency before the first spike in a series
CC       of action potentials, regulates the frequency of repetitive action
CC       potential firing, shortens the duration of action potentials and
CC       regulates the back-propagation of action potentials from the neuronal
CC       cell body to the dendrites. Contributes to the regulation of the
CC       circadian rhythm of action potential firing in suprachiasmatic nucleus
CC       neurons, which regulates the circadian rhythm of locomotor activity (By
CC       similarity). Functions downstream of the metabotropic glutamate
CC       receptor GRM5 and plays a role in neuronal excitability and in
CC       nociception mediated by activation of GRM5 (By similarity). Mediates
CC       the transient outward current I(to) in rodent heart left ventricle apex
CC       cells, but not in human heart, where this current is mediated by
CC       another family member (PubMed:9058605, PubMed:9093524). Forms
CC       tetrameric potassium-selective channels through which potassium ions
CC       pass in accordance with their electrochemical gradient. The channel
CC       alternates between opened and closed conformations in response to the
CC       voltage difference across the membrane (PubMed:10676964,
CC       PubMed:12451113, PubMed:12592409, PubMed:12754210, PubMed:14980206,
CC       PubMed:15452711, PubMed:16207878, PubMed:16820361, PubMed:1722463,
CC       PubMed:1840649, PubMed:25352783, PubMed:9093524). Can form functional
CC       homotetrameric channels and heterotetrameric channels that contain
CC       variable proportions of KCND2 and KCND3; channel properties depend on
CC       the type of pore-forming alpha subunits that are part of the channel
CC       (PubMed:25352783). In vivo, membranes probably contain a mixture of
CC       heteromeric potassium channel complexes (PubMed:12451113,
CC       PubMed:16123112). Interaction with specific isoforms of the regulatory
CC       subunits KCNIP1, KCNIP2, KCNIP3 or KCNIP4 strongly increases expression
CC       at the cell surface and thereby increases channel activity; it
CC       modulates the kinetics of channel activation and inactivation, shifts
CC       the threshold for channel activation to more negative voltage values,
CC       shifts the threshold for inactivation to less negative voltages and
CC       accelerates recovery after inactivation (PubMed:12451113,
CC       PubMed:14980206, PubMed:15452711, PubMed:16123112, PubMed:16820361,
CC       PubMed:20045463). Likewise, interaction with DPP6 or DPP10 promotes
CC       expression at the cell membrane and regulates both channel
CC       characteristics and activity (PubMed:15671030, PubMed:16123112,
CC       PubMed:19279261, PubMed:19441798, PubMed:19901547). Upon
CC       depolarization, the channel goes from a resting closed state (C state)
CC       to an activated but non-conducting state (C* state), from there, the
CC       channel may either inactivate (I state) or open (O state) (By
CC       similarity). {ECO:0000250|UniProtKB:Q9NZV8,
CC       ECO:0000250|UniProtKB:Q9Z0V2, ECO:0000269|PubMed:10676964,
CC       ECO:0000269|PubMed:11847232, ECO:0000269|PubMed:12451113,
CC       ECO:0000269|PubMed:12592409, ECO:0000269|PubMed:12754210,
CC       ECO:0000269|PubMed:14980206, ECO:0000269|PubMed:15452711,
CC       ECO:0000269|PubMed:15485870, ECO:0000269|PubMed:16123112,
CC       ECO:0000269|PubMed:16207878, ECO:0000269|PubMed:16820361,
CC       ECO:0000269|PubMed:17026528, ECO:0000269|PubMed:1722463,
CC       ECO:0000269|PubMed:17582333, ECO:0000269|PubMed:1840649,
CC       ECO:0000269|PubMed:19279261, ECO:0000269|PubMed:19441798,
CC       ECO:0000269|PubMed:19901547, ECO:0000269|PubMed:24404150,
CC       ECO:0000269|PubMed:25352783, ECO:0000269|PubMed:9058605,
CC       ECO:0000269|PubMed:9093524, ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:12451113, ECO:0000269|PubMed:12754210,
CC         ECO:0000269|PubMed:14980206, ECO:0000269|PubMed:15452711,
CC         ECO:0000269|PubMed:15485870, ECO:0000269|PubMed:15671030,
CC         ECO:0000269|PubMed:16123112, ECO:0000269|PubMed:16207878,
CC         ECO:0000269|PubMed:16820361, ECO:0000269|PubMed:17026528,
CC         ECO:0000269|PubMed:1722463, ECO:0000269|PubMed:17582333,
CC         ECO:0000269|PubMed:18276729, ECO:0000269|PubMed:1840649,
CC         ECO:0000269|PubMed:19901547, ECO:0000269|PubMed:20045463,
CC         ECO:0000269|PubMed:9058605, ECO:0000269|PubMed:9093524};
CC   -!- ACTIVITY REGULATION: Inhibited by 5 mM 4-aminopyridine (4-AP)
CC       (PubMed:1722463, PubMed:1840649, PubMed:9093524). Not inhibited by
CC       dendrotoxins and by tetraethylammonium (TEA) (PubMed:1722463).
CC       Inhibited by 10 mM flecainide and 20 mM quinidine (PubMed:9093524).
CC       Inhibited by the heteropodatoxins HpTx(1), HpTx(2), and HpTx(3)
CC       (PubMed:9058605). {ECO:0000269|PubMed:1722463,
CC       ECO:0000269|PubMed:1840649, ECO:0000269|PubMed:9058605,
CC       ECO:0000269|PubMed:9093524}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels activate rapidly, i.e within a few msec
CC         (PubMed:1722463, PubMed:9093524). After that, they inactivate
CC         rapidly, i.e within about 50-100 msec (PubMed:1722463,
CC         PubMed:9093524). The voltage-dependence of activation and
CC         inactivation and other channel characteristics vary depending on the
CC         experimental conditions, the expression system and the presence or
CC         absence of ancillary subunits (PubMed:19279261, PubMed:19901547).
CC         Homotetrameric channels have a unitary conductance of about 4 pS when
CC         expressed in a heterologous system (PubMed:19279261). For the
CC         activation of homotetrameric channels expressed in xenopus oocytes,
CC         the voltage at half-maximal amplitude is about -10 mV
CC         (PubMed:12451113). The time constant for inactivation is about 20
CC         msec (PubMed:12451113). For inactivation, the voltage at half-maximal
CC         amplitude is -62 mV (PubMed:12451113). The time constant for recovery
CC         after inactivation is about 70 msec (PubMed:12451113).
CC         {ECO:0000269|PubMed:12451113, ECO:0000269|PubMed:1722463,
CC         ECO:0000269|PubMed:19279261, ECO:0000269|PubMed:19901547,
CC         ECO:0000269|PubMed:9093524, ECO:0000305|PubMed:15858231};
CC   -!- SUBUNIT: Homotetramer or heterotetramer with KCND1 or KCND3
CC       (PubMed:12754210, PubMed:15485870, PubMed:20224290, PubMed:25352783).
CC       Associates with the regulatory subunits KCNIP2, KCNIP3 and KCNIP4
CC       (PubMed:10676964, PubMed:11805342, PubMed:11847232, PubMed:12451113,
CC       PubMed:14980206, PubMed:15356203, PubMed:15452711, PubMed:15485870,
CC       PubMed:16820361, PubMed:20045463, PubMed:24811166). Interacts with the
CC       regulatory subunit KCNIP1; this interaction mediates the capture of
CC       both the N- and C-terminus of KCND2, preventing N-type inactivation and
CC       stabilizing the S6 conformation, thereby accelerating closed state
CC       inactivation and recovery (PubMed:14980206, PubMed:14980207,
CC       PubMed:15356203). Interacts with DPP10, DLG4 and DLG1 (PubMed:11923279,
CC       PubMed:14559911, PubMed:15671030, PubMed:19213956). In vivo, probably
CC       exists as heteromeric complex containing variable proportions of KCND1,
CC       KCND2, KCND3, KCNIP1, KCNIP2, KCNIP3, KCNIP4, DPP6 and DPP10
CC       (PubMed:16123112, PubMed:19901547). The tetrameric channel can
CC       associate with up to four regulatory subunits, such as KCNIP2 or KCNIP4
CC       (By similarity). Interaction with KCNIP3 promotes tetramerization and
CC       formation of a functional potassium channel (PubMed:15485870).
CC       Interaction with four KCNIP4 chains does not reduce interaction with
CC       DPP10 (By similarity). Probably part of a complex consisting of KCNIP1,
CC       KCNIP2 isoform 3 and KCND2 (By similarity). Interacts with FLNA and
CC       FLNC (PubMed:11102480). Interacts with NCS1/FREQ (By similarity).
CC       Identified in a complex with cAMP-dependent protein kinase (PKA), CAV3,
CC       AKAP6 and KCND3 in cardiac myocytes (PubMed:20224290). Interacts (via
CC       S1 and S2 helices) with DPP6; this interaction stabilizes the
CC       conformation of the S1-S2 helices and facilitates S4 conformational
CC       change, including S4 sliding up and down, thereby accelerating
CC       activation, inactivation, and recovery (PubMed:12575952,
CC       PubMed:15671030). {ECO:0000250|UniProtKB:Q9NZV8,
CC       ECO:0000250|UniProtKB:Q9Z0V2, ECO:0000269|PubMed:10676964,
CC       ECO:0000269|PubMed:11102480, ECO:0000269|PubMed:11805342,
CC       ECO:0000269|PubMed:11847232, ECO:0000269|PubMed:11923279,
CC       ECO:0000269|PubMed:12451113, ECO:0000269|PubMed:12575952,
CC       ECO:0000269|PubMed:12754210, ECO:0000269|PubMed:14559911,
CC       ECO:0000269|PubMed:14980206, ECO:0000269|PubMed:14980207,
CC       ECO:0000269|PubMed:15356203, ECO:0000269|PubMed:15452711,
CC       ECO:0000269|PubMed:15485870, ECO:0000269|PubMed:15671030,
CC       ECO:0000269|PubMed:16123112, ECO:0000269|PubMed:16207878,
CC       ECO:0000269|PubMed:16820361, ECO:0000269|PubMed:19213956,
CC       ECO:0000269|PubMed:20224290, ECO:0000269|PubMed:24811166,
CC       ECO:0000269|PubMed:25352783, ECO:0000305|PubMed:19441798,
CC       ECO:0000305|PubMed:19901547}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10676964,
CC       ECO:0000269|PubMed:10860776, ECO:0000269|PubMed:11102480,
CC       ECO:0000269|PubMed:11847232, ECO:0000269|PubMed:12451113,
CC       ECO:0000269|PubMed:12592409, ECO:0000269|PubMed:12754210,
CC       ECO:0000269|PubMed:12829703, ECO:0000269|PubMed:14559911,
CC       ECO:0000269|PubMed:14980206, ECO:0000269|PubMed:15452711,
CC       ECO:0000269|PubMed:15485870, ECO:0000269|PubMed:15671030,
CC       ECO:0000269|PubMed:15736227, ECO:0000269|PubMed:16123112,
CC       ECO:0000269|PubMed:16820361, ECO:0000269|PubMed:1722463,
CC       ECO:0000269|PubMed:17582333, ECO:0000269|PubMed:18371079,
CC       ECO:0000269|PubMed:1840649, ECO:0000269|PubMed:18650329,
CC       ECO:0000269|PubMed:20045463, ECO:0000269|PubMed:22098631,
CC       ECO:0000269|PubMed:24793047, ECO:0000269|PubMed:25352783,
CC       ECO:0000269|PubMed:9070739, ECO:0000269|PubMed:9093524}; Multi-pass
CC       membrane protein {ECO:0000305}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:11102480,
CC       ECO:0000269|PubMed:12592409, ECO:0000269|PubMed:15736227,
CC       ECO:0000269|PubMed:16207878, ECO:0000269|PubMed:17582333,
CC       ECO:0000269|PubMed:18371079, ECO:0000269|PubMed:20224290,
CC       ECO:0000269|PubMed:22098631, ECO:0000269|PubMed:24037673,
CC       ECO:0000269|PubMed:24404150, ECO:0000269|PubMed:9070739}. Synapse
CC       {ECO:0000269|PubMed:11102480, ECO:0000269|PubMed:15736227,
CC       ECO:0000269|PubMed:17582333, ECO:0000269|PubMed:9070739}. Perikaryon
CC       {ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:15736227,
CC       ECO:0000269|PubMed:16207878, ECO:0000269|PubMed:18371079,
CC       ECO:0000269|PubMed:22098631, ECO:0000269|PubMed:9070739}. Postsynaptic
CC       cell membrane {ECO:0000269|PubMed:15736227,
CC       ECO:0000269|PubMed:9070739}. Cell projection, dendritic spine
CC       {ECO:0000269|PubMed:17582333, ECO:0000269|PubMed:18650329,
CC       ECO:0000269|PubMed:22098631, ECO:0000269|PubMed:24037673,
CC       ECO:0000269|PubMed:9070739}. Cell membrane, sarcolemma
CC       {ECO:0000269|PubMed:10860776}. Cell junction
CC       {ECO:0000269|PubMed:18371079}. Membrane, caveola
CC       {ECO:0000269|PubMed:20224290}. Note=In neurons, primarily detected on
CC       dendrites, dendritic spines and on the neuron cell body, but not on
CC       axons (PubMed:16207878, PubMed:17582333, PubMed:22098631,
CC       PubMed:9070739). Localized preferentially at the dendrites of pyramidal
CC       cells in the hippocampus CA1 layer (PubMed:22098631). Detected at
CC       GABAergic synapses (By similarity). Detected at cell junctions that are
CC       distinct from synaptic cell contacts (PubMed:18371079). Detected in
CC       lipid rafts (PubMed:14559911, PubMed:20224290, PubMed:24793047).
CC       Detected primarily at the endoplasmic reticulum or Golgi when expressed
CC       by itself (PubMed:12754210, PubMed:12829703, PubMed:14980206,
CC       PubMed:16820361, PubMed:19441798). Interaction with KCNIP1, KCNIP2,
CC       KCNIP3 or KCNIP4 promotes expression at the cell membrane
CC       (PubMed:12829703, PubMed:14980206, PubMed:15485870, PubMed:20045463).
CC       Interaction with DPP6 or DPP10 promotes expression at the cell membrane
CC       (PubMed:19441798). Internalized from the cell membrane by clathrin-
CC       dependent endocytosis in response to activation of AMPA-selective
CC       glutamate receptors and PKA-mediated phosphorylation at Ser-552
CC       (PubMed:17582333, PubMed:18650329). Redistributed from dendritic spines
CC       to the main dendritic shaft in response to activation of AMPA-selective
CC       glutamate receptors and activation of PKA (PubMed:17582333,
CC       PubMed:18650329). {ECO:0000250|UniProtKB:Q9Z0V2,
CC       ECO:0000269|PubMed:12754210, ECO:0000269|PubMed:14559911,
CC       ECO:0000269|PubMed:14980206, ECO:0000269|PubMed:15485870,
CC       ECO:0000269|PubMed:16207878, ECO:0000269|PubMed:16820361,
CC       ECO:0000269|PubMed:17582333, ECO:0000269|PubMed:18650329,
CC       ECO:0000269|PubMed:19441798, ECO:0000269|PubMed:20045463,
CC       ECO:0000269|PubMed:20224290, ECO:0000269|PubMed:22098631,
CC       ECO:0000269|PubMed:24793047, ECO:0000269|PubMed:9070739, ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Detected in brain cortex, hippocampus, dentate
CC       gyrus, thalamus and cerebellum (PubMed:16123112). Detected in neurons
CC       from the primary visual cortex (PubMed:16207878). Detected in the
CC       supraoptic nucleus in hypothalamus, in hippocampus and the habenular
CC       nucleus of the thalamus (PubMed:9070739). Detected in the bed nucleus
CC       of the stria terminalis (PubMed:24037673). Detected in dendritic fields
CC       in the hippocampus CA1 layer, in stratum radiatum, stratum oriens,
CC       stratum lacunosum-moleculare and stratum pyramidale (PubMed:10676964,
CC       PubMed:22098631). Detected in dendritic fields in the hippocampus CA3
CC       layer and in dentate gyrus (PubMed:10676964). Detected in the
CC       cerebellum granule cell layer, where it localizes at synapses
CC       (PubMed:10676964, PubMed:11102480, PubMed:15736227). Detected in the
CC       main olfactory bulb, especially in the granule cell layer and the
CC       external plexiform layer, but also the mitral layer (PubMed:18371079).
CC       Detected in heart atrium and ventricle (PubMed:10860776). Detected in
CC       heart left ventricle (at protein level) (PubMed:24793047). Highly
CC       expressed in heart and throughout the brain, with similar levels in
CC       cortex and hypothalamus, and much higher levels in hippocampus, dentate
CC       gyrus and the habenular nucleus of the thalamus. Detected in brain, and
CC       at lower levels in heart atrium and ventricle (PubMed:1705709).
CC       Detected in neurons from the bed nucleus of the stria terminalis
CC       (PubMed:24037673). Detected in aorta, cardiac and smooth muscle.
CC       {ECO:0000269|PubMed:10676964, ECO:0000269|PubMed:11102480,
CC       ECO:0000269|PubMed:15736227, ECO:0000269|PubMed:16123112,
CC       ECO:0000269|PubMed:16207878, ECO:0000269|PubMed:1705709,
CC       ECO:0000269|PubMed:18371079, ECO:0000269|PubMed:1840649,
CC       ECO:0000269|PubMed:22098631, ECO:0000269|PubMed:24793047,
CC       ECO:0000269|PubMed:9070739}.
CC   -!- INDUCTION: Down-regulated in response to hypoxia lasting about 15
CC       minutes, a treatment that leads to spontaneous convulsive seizures in
CC       these pups. {ECO:0000269|PubMed:25352783}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as a voltage-sensor and
CC       is characterized by a series of positively charged amino acids at every
CC       third position. Channel opening and closing is effected by a
CC       conformation change that affects the position and orientation of the
CC       voltage-sensor paddle formed by S3 and S4 within the membrane. A
CC       transmembrane electric field that is positive inside would push the
CC       positively charged S4 segment outwards, thereby opening the pore, while
CC       a field that is negative inside would pull the S4 segment inwards and
CC       close the pore. Changes in the position and orientation of S4 are then
CC       transmitted to the activation gate formed by the inner helix bundle via
CC       the S4-S5 linker region. {ECO:0000250|UniProtKB:P63142}.
CC   -!- DOMAIN: The N-terminal cytoplasmic region can mediate N-type
CC       inactivation by physically blocking the channel (PubMed:15452711). This
CC       probably does not happen in vivo, where the N-terminal region mediates
CC       interaction with regulatory subunits, such as KCNIP1 and KCNIP2
CC       (PubMed:14980206, PubMed:16820361, PubMed:18357523). The zinc binding
CC       sites in the N-terminal domain are important for tetramerization and
CC       assembly of a functional channel complex (PubMed:12754210). The channel
CC       undergoes closed-state inactivation, where conformation changes lead to
CC       inactivation through an intermediate state involving breakdown of its
CC       4-fold symmetry. that governs the distinct transient, fast-inactivating
CC       currents (By similarity). {ECO:0000250|UniProtKB:Q9NZV8,
CC       ECO:0000269|PubMed:12754210, ECO:0000269|PubMed:16820361,
CC       ECO:0000305|PubMed:14980206, ECO:0000305|PubMed:15452711,
CC       ECO:0000305|PubMed:18357523}.
CC   -!- DOMAIN: The C-terminal cytoplasmic region is important for normal
CC       expression at the cell membrane and modulates the voltage-dependence of
CC       channel activation and inactivation. It is required for interaction
CC       with KCNIP2, and probably other family members as well.
CC       {ECO:0000269|PubMed:16820361}.
CC   -!- PTM: Phosphorylation at Ser-438 in response to MAPK activation is
CC       increased in stimulated dendrites (PubMed:24404150). Interaction with
CC       KCNIP2 and DPP6 propomtes phosphorylation by PKA at Ser-552
CC       (PubMed:19441798). Phosphorylation at Ser-552 has no effect on
CC       interaction with KCNIP3, but is required for the regulation of channel
CC       activity by KCNIP3 (PubMed:12451113). Phosphorylation at Ser-552 leads
CC       to KCND2 internalization (PubMed:17582333). Phosphorylated by MAPK in
CC       response to signaling via the metabotropic glutamate receptor GRM5 (By
CC       similarity). Phosphorylation at Ser-616 is required for the down-
CC       regulation of neuronal A-type currents in response to signaling via
CC       GRM5 (By similarity). {ECO:0000250|UniProtKB:Q9Z0V2,
CC       ECO:0000269|PubMed:12451113, ECO:0000269|PubMed:17582333,
CC       ECO:0000269|PubMed:19441798, ECO:0000269|PubMed:24404150}.
CC   -!- MISCELLANEOUS: The transient neuronal A-type potassium current called
CC       I(SA) is triggered at membrane potentials that are below the threshold
CC       for action potentials. It inactivates rapidly and recovers rapidly from
CC       inactivation. It regulates the firing of action potentials and plays a
CC       role in synaptic integration and plasticity. Potassium channels
CC       containing KCND2 account for about 80% of the neuronal A-type potassium
CC       current. In contrast, the potassium channel responsible for the cardiac
CC       I(to) current differs between species; it is mediated by KCND2 in
CC       rodents. In human and other non-rodents KCND3 may play an equivalent
CC       role. {ECO:0000269|PubMed:9093524, ECO:0000305|PubMed:17917103,
CC       ECO:0000305|PubMed:18357523}.
CC   -!- MISCELLANEOUS: Is specifically and reversibly inhibited by the scorpion
CC       toxin Ts8 (AC P69940). {ECO:0000269|PubMed:27346450}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. D (Shal) (TC
CC       1.A.1.2) subfamily. Kv4.2/KCND2 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA40929.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S64320; AAB19939.1; -; mRNA.
DR   EMBL; M59980; AAA40929.1; ALT_FRAME; mRNA.
DR   PIR; I57681; I57681.
DR   PIR; JU0271; JU0271.
DR   RefSeq; NP_113918.2; NM_031730.2.
DR   PDB; 1NN7; X-ray; 2.10 A; A=42-146.
DR   PDB; 1S6C; X-ray; 2.00 A; B=1-30.
DR   PDBsum; 1NN7; -.
DR   PDBsum; 1S6C; -.
DR   AlphaFoldDB; Q63881; -.
DR   SMR; Q63881; -.
DR   BioGRID; 249292; 2.
DR   CORUM; Q63881; -.
DR   IntAct; Q63881; 3.
DR   MINT; Q63881; -.
DR   BindingDB; Q63881; -.
DR   ChEMBL; CHEMBL1075227; -.
DR   DrugCentral; Q63881; -.
DR   GuidetoPHARMACOLOGY; 553; -.
DR   iPTMnet; Q63881; -.
DR   PhosphoSitePlus; Q63881; -.
DR   PaxDb; 10116-ENSRNOP00000039227; -.
DR   ABCD; Q63881; 3 sequenced antibodies.
DR   GeneID; 65180; -.
DR   KEGG; rno:65180; -.
DR   UCSC; RGD:68393; rat.
DR   AGR; RGD:68393; -.
DR   CTD; 3751; -.
DR   RGD; 68393; Kcnd2.
DR   eggNOG; KOG4390; Eukaryota.
DR   InParanoid; Q63881; -.
DR   OrthoDB; 1478695at2759; -.
DR   PhylomeDB; Q63881; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   Reactome; R-RNO-5576894; Phase 1 - inactivation of fast Na+ channels.
DR   EvolutionaryTrace; Q63881; -.
DR   PRO; PR:Q63881; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005901; C:caveola; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:UniProtKB.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0071193; C:Kv4.2-KChIP2 channel complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0097038; C:perinuclear endoplasmic reticulum; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0044853; C:plasma membrane raft; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0034705; C:potassium channel complex; IDA:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:UniProtKB.
DR   GO; GO:0030315; C:T-tubule; IDA:UniProtKB.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005250; F:A-type (transient outward) potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005216; F:monoatomic ion channel activity; IDA:RGD.
DR   GO; GO:0005267; F:potassium channel activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:1905030; F:voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; IMP:SynGO.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0001508; P:action potential; IMP:RGD.
DR   GO; GO:0086001; P:cardiac muscle cell action potential; IMP:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0045475; P:locomotor rhythm; ISO:RGD.
DR   GO; GO:0086009; P:membrane repolarization; ISO:RGD.
DR   GO; GO:0006936; P:muscle contraction; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; ISO:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0019233; P:sensory perception of pain; ISO:RGD.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003975; K_chnl_volt-dep_Kv4.
DR   InterPro; IPR004055; K_chnl_volt-dep_Kv4.2.
DR   InterPro; IPR024587; K_chnl_volt-dep_Kv4_C.
DR   InterPro; IPR021645; Shal-type_N.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR11537:SF265; POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY D MEMBER 2; 1.
DR   PANTHER; PTHR11537; VOLTAGE-GATED POTASSIUM CHANNEL; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF11879; DUF3399; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11601; Shal-type; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01517; KV42CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01497; SHALCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Postsynaptic cell membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel; Zinc.
FT   CHAIN           1..630
FT                   /note="A-type voltage-gated potassium channel KCND2"
FT                   /id="PRO_0000054067"
FT   TOPO_DOM        1..184
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TRANSMEM        185..206
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TOPO_DOM        207..226
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TRANSMEM        227..249
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TOPO_DOM        250..256
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TRANSMEM        257..281
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TOPO_DOM        282..287
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TRANSMEM        288..307
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TOPO_DOM        308..321
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TRANSMEM        322..345
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TOPO_DOM        346..357
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   INTRAMEM        358..369
FT                   /note="Helical; Name=Pore helix"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   INTRAMEM        370..377
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   TOPO_DOM        378..380
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TRANSMEM        381..403
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   TOPO_DOM        404..630
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   REGION          2..20
FT                   /note="Interaction with KCNIP1, KCNIP2, and other family
FT                   members"
FT                   /evidence="ECO:0000305|PubMed:14980206,
FT                   ECO:0000305|PubMed:14980207"
FT   REGION          71..90
FT                   /note="Interaction with KCNIP1"
FT                   /evidence="ECO:0000305|PubMed:14980207"
FT   REGION          308..321
FT                   /note="S4-S5 linker"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   REGION          474..630
FT                   /note="Important for normal channel activation and
FT                   inactivation, for interaction with KCNIP2, and probably
FT                   other family members as well"
FT                   /evidence="ECO:0000305|PubMed:16820361"
FT   REGION          474..489
FT                   /note="Required for dendritic targeting"
FT                   /evidence="ECO:0000269|PubMed:12592409"
FT   REGION          600..623
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           370..375
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   MOTIF           627..630
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000269|PubMed:11923279,
FT                   ECO:0000269|PubMed:14559911"
FT   BINDING         105
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /note="in chain A"
FT                   /evidence="ECO:0000269|PubMed:12835418,
FT                   ECO:0007744|PDB:1NN7"
FT   BINDING         111
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /note="in chain B"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   BINDING         132
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /note="in chain A"
FT                   /evidence="ECO:0000269|PubMed:12835418,
FT                   ECO:0007744|PDB:1NN7"
FT   BINDING         133
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /note="in chain A"
FT                   /evidence="ECO:0000269|PubMed:12835418,
FT                   ECO:0007744|PDB:1NN7"
FT   BINDING         370
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   BINDING         371
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   BINDING         372
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   BINDING         373
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZV8"
FT   MOD_RES         38
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:10681507"
FT   MOD_RES         438
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:24404150"
FT   MOD_RES         548
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19441798,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         552
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10681507,
FT                   ECO:0000269|PubMed:12451113, ECO:0000269|PubMed:12829703,
FT                   ECO:0000269|PubMed:18650329, ECO:0000269|PubMed:19441798,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         572
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19441798,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         575
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19441798,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         602
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:11080179"
FT   MOD_RES         607
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:11080179"
FT   MOD_RES         616
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:11080179"
FT   MUTAGEN         7..11
FT                   /note="Missing: Greatly reduces interaction with KCNIP1."
FT                   /evidence="ECO:0000269|PubMed:14980207"
FT   MUTAGEN         8
FT                   /note="W->A: Abolishes interaction with KCNP1; when
FT                   associated with A-11."
FT                   /evidence="ECO:0000269|PubMed:14980206"
FT   MUTAGEN         11
FT                   /note="F->A: Abolishes interaction with KCNP1; when
FT                   associated with A-8."
FT                   /evidence="ECO:0000269|PubMed:14980206"
FT   MUTAGEN         66
FT                   /note="L->R: Abolishes expression."
FT                   /evidence="ECO:0000269|PubMed:12835418"
FT   MUTAGEN         71
FT                   /note="E->K: Abolishes interaction with KCNIP1."
FT                   /evidence="ECO:0000269|PubMed:14980207"
FT   MUTAGEN         73
FT                   /note="D->M: Abolishes interaction with KCNIP1."
FT                   /evidence="ECO:0000269|PubMed:14980207"
FT   MUTAGEN         74
FT                   /note="F->R: Abolishes interaction with KCNIP1."
FT                   /evidence="ECO:0000269|PubMed:14980207"
FT   MUTAGEN         79
FT                   /note="E->L,R: Abolishes interaction with KCNIP1."
FT                   /evidence="ECO:0000269|PubMed:14980207"
FT   MUTAGEN         93
FT                   /note="R->A: Greatly reduces expression and changes
FT                   multimerization."
FT                   /evidence="ECO:0000269|PubMed:12835418"
FT   MUTAGEN         105
FT                   /note="H->A: Abolishes tetramerization and assembly of a
FT                   functional channel."
FT                   /evidence="ECO:0000269|PubMed:12754210"
FT   MUTAGEN         111
FT                   /note="C->A: Abolishes tetramerization and assembly of a
FT                   functional channel; when associated with A-105; A-132 and
FT                   A-133."
FT                   /evidence="ECO:0000269|PubMed:12754210"
FT   MUTAGEN         132
FT                   /note="C->A: Abolishes tetramerization and assembly of a
FT                   functional channel; when associated with A-105; A-111 and
FT                   A-133."
FT                   /evidence="ECO:0000269|PubMed:12754210"
FT   MUTAGEN         133
FT                   /note="C->A: Abolishes tetramerization and assembly of a
FT                   functional channel; when associated with A-105; A-111 and
FT                   A-132."
FT                   /evidence="ECO:0000269|PubMed:12754210"
FT   MUTAGEN         481..482
FT                   /note="Missing: Loss of dendritic targeted expression."
FT                   /evidence="ECO:0000269|PubMed:12592409"
FT   MUTAGEN         552
FT                   /note="S->A: Abolishes PKA-mediated modulation of cell
FT                   surface expression and channel activity."
FT                   /evidence="ECO:0000269|PubMed:12451113,
FT                   ECO:0000269|PubMed:18650329"
FT   MUTAGEN         627..630
FT                   /note="Missing: Abolishes interaction with DLG4."
FT                   /evidence="ECO:0000269|PubMed:11923279,
FT                   ECO:0000269|PubMed:14559911"
FT   HELIX           1..6
FT                   /evidence="ECO:0007829|PDB:1S6C"
FT   HELIX           9..17
FT                   /evidence="ECO:0007829|PDB:1S6C"
FT   STRAND          43..47
FT                   /evidence="ECO:0007829|PDB:1NN7"
FT   STRAND          50..54
FT                   /evidence="ECO:0007829|PDB:1NN7"
FT   HELIX           56..60
FT                   /evidence="ECO:0007829|PDB:1NN7"
FT   STRAND          64..66
FT                   /evidence="ECO:0007829|PDB:1NN7"
FT   HELIX           70..75
FT                   /evidence="ECO:0007829|PDB:1NN7"
FT   HELIX           78..80
FT                   /evidence="ECO:0007829|PDB:1NN7"
FT   STRAND          81..85
FT                   /evidence="ECO:0007829|PDB:1NN7"
FT   TURN            89..91
FT                   /evidence="ECO:0007829|PDB:1NN7"
FT   HELIX           92..101
FT                   /evidence="ECO:0007829|PDB:1NN7"
FT   HELIX           112..122
FT                   /evidence="ECO:0007829|PDB:1NN7"
FT   HELIX           131..145
FT                   /evidence="ECO:0007829|PDB:1NN7"
SQ   SEQUENCE   630 AA;  70549 MW;  FDE57E8A5113BABF CRC64;
     MAAGVAAWLP FARAAAIGWM PVASGPMPAP PRQERKRTQD ALIVLNVSGT RFQTWQDTLE
     RYPDTLLGSS ERDFFYHPET QQYFFDRDPD IFRHILNFYR TGKLHYPRHE CISAYDEELA
     FFGLIPEIIG DCCYEEYKDR RRENAERLQD DADTDNTGES ALPTMTARQR VWRAFENPHT
     STMALVFYYV TGFFIAVSVI ANVVETVPCG SSPGHIKELP CGERYAVAFF CLDTACVMIF
     TVEYLLRLAA APSRYRFVRS VMSIIDVVAI LPYYIGLVMT DNEDVSGAFV TLRVFRVFRI
     FKFSRHSQGL RILGYTLKSC ASELGFLLFS LTMAIIIFAT VMFYAEKGSS ASKFTSIPAA
     FWYTIVTMTT LGYGDMVPKT IAGKIFGSIC SLSGVLVIAL PVPVIVSNFS RIYHQNQRAD
     KRRAQKKARL ARIRAAKSGS ANAYMQSKRN GLLSNQLQSS EDEPAFVSKS GSSFETQHHH
     LLHCLEKTTN HEFVDEQVFE ESCMEVATVN RPSSHSPSLS SQQGVTSTCC SRRHKKSFRI
     PNANVSGSHR GSVQELSTIQ IRCVERTPLS NSRSSLNAKM EECVKLNCEQ PYVTTAIISI
     PTPPVTTPEG DDRPESPEYS GGNIVRVSAL
//
